Medlive Technology Statistics
Total Valuation
HKG:2192 has a market cap or net worth of HKD 6.95 billion. The enterprise value is 2.86 billion.
Market Cap | 6.95B |
Enterprise Value | 2.86B |
Important Dates
The next estimated earnings date is Monday, March 24, 2025.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | Oct 22, 2024 |
Share Statistics
HKG:2192 has 732.88 million shares outstanding. The number of shares has increased by 0.03% in one year.
Current Share Class | n/a |
Shares Outstanding | 732.88M |
Shares Change (YoY) | +0.03% |
Shares Change (QoQ) | +1.01% |
Owned by Insiders (%) | 1.58% |
Owned by Institutions (%) | 22.95% |
Float | 186.21M |
Valuation Ratios
The trailing PE ratio is 22.36 and the forward PE ratio is 23.31.
PE Ratio | 22.36 |
Forward PE | 23.31 |
PS Ratio | 13.30 |
PB Ratio | 1.37 |
P/TBV Ratio | 1.46 |
P/FCF Ratio | 71.60 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.25, with an EV/FCF ratio of 29.50.
EV / Earnings | 9.18 |
EV / Sales | 5.53 |
EV / EBITDA | 24.25 |
EV / EBIT | 26.84 |
EV / FCF | 29.50 |
Financial Position
The company has a current ratio of 26.91, with a Debt / Equity ratio of 0.00.
Current Ratio | 26.91 |
Quick Ratio | 26.64 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.15 |
Debt / FCF | 0.18 |
Interest Coverage | 231.37 |
Financial Efficiency
Return on equity (ROE) is 6.46% and return on invested capital (ROIC) is 1.32%.
Return on Equity (ROE) | 6.46% |
Return on Assets (ROA) | 1.26% |
Return on Invested Capital (ROIC) | 1.32% |
Return on Capital Employed (ROCE) | 2.07% |
Revenue Per Employee | 694,161 |
Profits Per Employee | 418,135 |
Employee Count | 742 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.54% in the last 52 weeks. The beta is 0.55, so HKG:2192's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | +44.54% |
50-Day Moving Average | 9.34 |
200-Day Moving Average | 8.36 |
Relative Strength Index (RSI) | 42.19 |
Average Volume (20 Days) | 466,588 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2192 had revenue of HKD 517.84 million and earned 311.93 million in profits. Earnings per share was 0.42.
Revenue | 517.84M |
Gross Profit | 315.30M |
Operating Income | 106.65M |
Pretax Income | 331.61M |
Net Income | 311.93M |
EBITDA | 111.67M |
EBIT | 106.65M |
Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 4.15 billion in cash and 17.24 million in debt, giving a net cash position of 4.14 billion or 5.64 per share.
Cash & Cash Equivalents | 4.15B |
Total Debt | 17.24M |
Net Cash | 4.14B |
Net Cash Per Share | 5.64 |
Equity (Book Value) | 5.08B |
Book Value Per Share | 6.92 |
Working Capital | 4.18B |
Cash Flow
In the last 12 months, operating cash flow was 98.79 million and capital expenditures -1.75 million, giving a free cash flow of 97.04 million.
Operating Cash Flow | 98.79M |
Capital Expenditures | -1.75M |
Free Cash Flow | 97.04M |
FCF Per Share | 0.13 |
Margins
Gross margin is 60.89%, with operating and profit margins of 20.60% and 60.24%.
Gross Margin | 60.89% |
Operating Margin | 20.60% |
Pretax Margin | 64.04% |
Profit Margin | 60.24% |
EBITDA Margin | 21.56% |
EBIT Margin | 20.60% |
FCF Margin | 18.74% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 3.12%.
Dividend Per Share | 0.27 |
Dividend Yield | 3.12% |
Dividend Growth (YoY) | 40.95% |
Years of Dividend Growth | 3 |
Payout Ratio | 74.20% |
Buyback Yield | -0.03% |
Shareholder Yield | 3.09% |
Earnings Yield | 4.49% |
FCF Yield | 1.40% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:2192 has an Altman Z-Score of 15.3.
Altman Z-Score | 15.3 |
Piotroski F-Score | n/a |